Guy Young
Pediatric Hematology-Oncology · Bozeman, MTNPI 1629175195
Payments from drug & device makers
What this record shows
The money is spread across several categories — speaking fees (53.2%), consulting fees and travel and lodging — rather than concentrated in one kind of arrangement. 38 manufacturers reported payments, led by Sanofi at 32.9% of the total.
Across 1,587 payments — averaging $1585.93 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Sanofi$829K
- CSL Behring$300K
- HEMA Biologics, LLC$262K
- Biomarin Pharmaceutical Inc.$166K
- Novo Nordisk$153K
- Novo Nordisk Health Care AG$152K
- plus $656K from 32 others
Across 1,421 payments — averaging $1841.81 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Genentech, Inc.$560K
- Novo Nordisk AS$554K
- Takeda Pharmaceuticals U.S.A., Inc.$411K
- Grifols Shared Services North America, Inc.$283K
- Sanofi US Services Inc.$256K
- Sanofi$244K
- plus $310K from 7 others
What the payments were for
- Consulting fees$758,67230%
- Speaking & faculty fees$1,338,46653%
- Travel & lodging$390,07515%
- Food & beverage$28,6071%
- Education$1,0320%
- Gifts$120%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- HEMGENIX$283,311
- SevenFact$256,795
- ALTUVIIIO$239,749
- HEMLIBRA$194,161
- ALPROLIX$138,127
- ELOCTATE$119,041
- QFITLIA$115,229
- NUWIQ$59,065
- Roctavian$44,100
- REBINYN$31,872
- Non-Covered Product$27,254
- FEIBA$25,118
- Novoeight$25,073
- CEPROTIN$18,960
- Idelvion$18,558
- HYMPAVZI$16,745
- Alhemo$15,129
- Jivi$11,903
- Esperoct$9,800
- Alphanate$7,400
How this compares
Too few pediatric hematology-oncology providers in Montanato place this figure against a meaningful peer group, so we don't.
Other pediatric hematology-oncology in Bozeman
- Allie MaffitKalispell$88
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.